BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16445632)

  • 41. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.
    Nanki Y; Chiyoda T; Kataoka F; Nomura H; Nakadaira N; Iwasa N; Hashimoto S; Arima H; Susumu N; Aoki D
    J Obstet Gynaecol Res; 2017 Apr; 43(4):744-748. PubMed ID: 28370831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.
    Cho HY; Kyung MS
    Med Sci Monit; 2014 Jul; 20():1334-9. PubMed ID: 25073801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-stratified analysis of tumor markers and tumor characteristics in adolescents and young women with mature cystic teratoma.
    Yesilyurt H; Seckin B; Aktulay A; Ozyer S
    J Chin Med Assoc; 2018 Jun; 81(6):499-504. PubMed ID: 28826726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mature cystic teratomas: relationship between histopathological contents and clinical features.
    Cakmak B; Nacar M; Ozsoy Z; Aliyev N; Koseoglu D
    Niger J Clin Pract; 2015; 18(2):236-9. PubMed ID: 25665999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S; Shen L; Qian N; Chen K
    Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.
    Sasaki A; Kawano K; Inomata M; Shibata K; Matsumoto T; Kitano S
    Hepatogastroenterology; 2005; 52(66):1814-9. PubMed ID: 16334783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma.
    Chen Z; Wang Y; Fang M
    Cancer Med; 2020 Feb; 9(4):1392-1399. PubMed ID: 31881123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma.
    Saygili U; Guclu S; Uslu T; Erten O; Dogan E
    Int J Gynecol Cancer; 2002; 12(5):438-42. PubMed ID: 12366659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population.
    Zhang D; Yu M; Xu T; Xiong B
    Hepatogastroenterology; 2013 Sep; 60(126):1297-301. PubMed ID: 23933921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ovary teratoma. Report of 91 cases].
    Sahraoui W; Hajji S; Essefi A; Haouas N; Hmissa S; Bibi M; Khairi H
    Tunis Med; 2006 Jun; 84(6):349-52. PubMed ID: 17042207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer.
    Namikawa T; Kawanishi Y; Fujisawa K; Munekage E; Iwabu J; Munekage M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Surg Today; 2018 Apr; 48(4):388-394. PubMed ID: 29043453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.
    Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W
    Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis.
    Harada T; Kubota T; Aso T
    Fertil Steril; 2002 Oct; 78(4):733-9. PubMed ID: 12372448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
    Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
    Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Squamous cell carcinoma arising in a mature cystic teratoma of the ovary in young patient with elevated carbohydrate antigen 19-9.
    Arioz DT; Tokyol C; Sahin FK; Koker G; Yilmaz S; Yilmazer M; Ozalp S
    Eur J Gynaecol Oncol; 2008; 29(3):282-4. PubMed ID: 18592797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma.
    Qiu Y; He J; Chen X; Huang P; Hu K; Yan H
    Clin Chim Acta; 2018 May; 480():186-192. PubMed ID: 29438681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.